Epidemiology, etiology, prognosis and presentation of malignant pleural mesothelioma

Kristiaan Nackaerts (Leuven, Belgium)

Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Number: 1
Disease area: Thoracic oncology

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kristiaan Nackaerts (Leuven, Belgium). Epidemiology, etiology, prognosis and presentation of malignant pleural mesothelioma. ERS Online Course 2020: Calendar sheets in malignant pleural diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015

Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012

Epidemiology and clinical problems of orphant pleural adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Diagnosis of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Malignant pleural mesothelioma: new treatment modalities
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Source: Eur Respir Rev 2016; 25: 472-486
Year: 2016



Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010

Management of malignant mesothelioma
Source: ERS Skills Course 2018 - Practical Pleural Skills
Year: 2018

A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013



Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013